AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2021
Dec 15, 2021
31580_dirs_2021-12-15_18fb29fb-8d79-44c9-9527-252e904d1a5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2021-12-06
Reporting Person: Poddar Richa (Chief Commercial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 150 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted stock units | $ | Common stock (658.0) | Direct | ||
| Restricted stock units | $ | Common stock (3476.0) | Direct | ||
| Restricted stock units | $ | Common stock (5000.0) | Direct | ||
| Restricted stock units | $ | Common stock (6204.0) | Direct | ||
| Stock options (right to buy) | $59.68 | 2026-06-06 | Common stock (5100.0) | Direct | |
| Stock options (right to buy) | $50.4 | 2027-02-21 | Common stock (3650.0) | Direct | |
| Stock options (right to buy) | $77.7 | 2028-02-16 | Common stock (6860.0) | Direct | |
| Stock options (right to buy) | $58.86 | 2029-02-22 | Common stock (7900.0) | Direct | |
| Stock options (right to buy) | $51.51 | 2030-02-14 | Common stock (2607.0) | Direct | |
| Stock options (right to buy) | $56.68 | 2031-02-10 | Common stock (3102.0) | Direct |
Footnotes
F1: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
F4: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.
F5: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
F6: This option was granted on June 6, 2016. The shares underlying this option are fully vested.
F7: This option was granted on February 21, 2017. The shares underlying this option are fully vested.
F8: This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F9: This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F10: This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F11: This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.